spánek, nespavost, poruchy spánku, snář, sny, sebediagnostika, spánková hygiena

Literatura


  • Brunner DP, Dijk DJ, Münch M, Borbély AA. Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology (Berl) 1991;104(1):1–5.
  • Diagnostic and Statistical Manual of Mental Disorders: Diagnostic Criteria for Primary Insomnia. FourthEdition. American Psychiatric Association 2000:597–661.
  • Leger D, Laudon M and Zisapel N. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. The American Journal of Medicine 2004;116(2):91–95.
  • Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 2007;16:372–380.
  • NEURIM 1, study report.
  • Otmani S, et al. 2008 (submitted).
  • Paul MA, Gray G, Sardana TM, Pigeau RA. Melatonin and zopiclone as facilitators of early circadian sleep in operational air transport crews. Aviat Space Environ Med 2004;75(5):439–443.
  • Traschsel L, Dijk DJ, Brunner DP, et al. Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advacned sleep schedule. Neuropsychopharmacology 1990;3(1):11–18.
  • Tyrer P, Murphy S, Riley P. The Benzodiazepine Withdrawal Symptom Questionnaire. Journal of Affective Disorders 1990;19:53-61.
  • Wade AG, Ford I, Crawford G, et al. Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness. Curr Med Res Opin 2007;23(10):2597–2605.
  • Waldhauser F, Waldhauser M, Lieberman HR, et al. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984:307–313.
 

Odborné akce

Pozvánky na semináře, kongresy
a sympozia.

více informací

 
 
Medicínská databáze U Lékaře
 
Cestovní nemoci:  Arabské trhy aneb Skrytá rizika číhající na turisty